Literature DB >> 3110678

Beta 2-microglobulin kinetics during haemodialysis and haemofiltration.

J Flöge, C Granolleras, M Bingel, G Deschodt, B Branger, R Oules, K M Koch, S Shaldon.   

Abstract

Since the identification of beta 2-microglobulin as a major component of 'dialysis amyloid', concern about its removal by different dialysis methods has been raised. Haemodialysis with regenerated cellulose membranes increases serum beta 2-microglobulin by 10-15%. Serial measurements show a very early increase during cuprophan haemodialysis, the mechanism of which is as yet unknown. After cuprophan haemodialysis, serum values return to the initial pretreatment concentrations by the time of the next haemodialysis. In contrast to regenerated cellulose, dialysis with polycarbonate lowers serum beta 2-microglobulin by 8%, and dialysis with polysulphone by 53%. As opposed to cuprophan, after polysulphone haemodialysis the serum concentrations have not returned to the initial pretreatment levels within 48 h. Comparison of beta 2-microglobulin removal using the same polysulphone membrane for haemodialysis and haemofiltration shows that beta 2-microglobulin is more effectively removed by convection than by diffusion when both treatment modes are matched for blood flow and urea clearance. Therefore, in contrast to haemodialysis with regenerated cellulose membranes, where a transient, intradialytic release of beta 2-microglobulin is induced, significant removal is observed using higher permeable membranes. These findings may have implications for the generation of 'dialysis amyloid'.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3110678

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  3 in total

Review 1.  beta 2-Microglobulin amyloidosis. A systemic amyloid disease affecting primarily synovium and bone in long-term dialysis patients.

Authors:  C P Maury
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

2.  Degranulation of peripheral blood neutrophils during haemoperfusion in chronic uraemics.

Authors:  K Trznadel; M Luciak; Z Zbróg; Z Kidawa
Journal:  Int Urol Nephrol       Date:  1988       Impact factor: 2.370

3.  Osteoarticular amyloidosis associated with haemodialysis: an immunoultrastructural study.

Authors:  M Depierreux; M Goldman; I Fayt; C Richard; J Quintin; M Dhaene; J L Van Herweghem
Journal:  J Clin Pathol       Date:  1988-02       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.